| scholarly article | Q13442814 |
| P2093 | author name string | Ronald Klein | |
| Frederick L Ferris | |||
| Johanna M Seddon | |||
| Traci E Clemons | |||
| Roy C Milton | |||
| P2860 | cites work | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 |
| Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3 | Q24545563 | ||
| Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians | Q28187481 | ||
| Body mass index and the incidence of visually significant age-related maculopathy in men | Q28188750 | ||
| An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration | Q28190470 | ||
| Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health | Q28288766 | ||
| Prevalence of age-related macular degeneration in the United States | Q29614964 | ||
| The prevalence of age-related maculopathy by geographic region and ethnicity | Q33587634 | ||
| The role of oxidative stress in the pathogenesis of age-related macular degeneration. | Q34060719 | ||
| The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study | Q34528853 | ||
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 | Q34655512 | ||
| Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. | Q34655518 | ||
| The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. | Q34655539 | ||
| The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. | Q36076822 | ||
| Ocular exposure to UV-B in sunlight: the Melbourne visual impairment project model | Q36795135 | ||
| Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women | Q39124241 | ||
| A prospective study of cigarette smoking and risk of age-related macular degeneration in men. | Q41128551 | ||
| Dietary fat and risk for advanced age-related macular degeneration | Q43694046 | ||
| The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. | Q43796210 | ||
| Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study | Q44147004 | ||
| Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study | Q44164361 | ||
| Early age-related maculopathy in the cardiovascular health study | Q44268950 | ||
| Risk factors for incident age-related macular degeneration: pooled findings from 3 continents | Q44545015 | ||
| Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study | Q44562120 | ||
| Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies | Q44605040 | ||
| Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake | Q44684814 | ||
| The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. | Q45905000 | ||
| Features of age-related macular degeneration in a black population. The Barbados Eye Study Group | Q46246780 | ||
| Race, macular degeneration, and the Macular Photocoagulation Study | Q48405236 | ||
| Risk factors for age-related macular degeneration: Pooled findings from three continents. | Q50506048 | ||
| Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. | Q50524204 | ||
| Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. | Q50528851 | ||
| Senile macular degeneration: a case-control study. | Q50927753 | ||
| Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. | Q50992620 | ||
| Association between C-reactive protein and age-related macular degeneration. | Q51051730 | ||
| The Radicals in Cigarette Tar: Their Nature and Suggested Physiological Implications | Q53559687 | ||
| Senile disciform macular degeneration and smoking | Q67325346 | ||
| Diabetes, hyperglycemia, and age-related maculopathy. The Beaver Dam Eye Study | Q67595690 | ||
| Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group | Q67803483 | ||
| The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels | Q68090477 | ||
| Risk factors of age-related maculopathy in a population 70 years of age or older | Q71108625 | ||
| A prospective study of cigarette smoking and age-related macular degeneration in women | Q71582100 | ||
| Dietary fat and age-related maculopathy | Q72325651 | ||
| Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study | Q73017230 | ||
| Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio | Q73501230 | ||
| Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III | Q77872867 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| macular degeneration | Q27429789 | ||
| P304 | page(s) | 533-9 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Ophthalmology | Q7098109 |
| P1476 | title | Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19 | |
| P478 | volume | 112 |
| Q33740158 | A Review of Current and Future Management of Geographic Atrophy |
| Q51127005 | A hybrid cohort individual sampling natural history model of age-related macular degeneration: assessing the cost-effectiveness of screening using probabilistic calibration. |
| Q33263803 | A review of drug options in age-related macular degeneration therapy and potential new agents |
| Q36055920 | A role for epigenetic changes in the development of retinal neurodegenerative conditions |
| Q37003860 | Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-alpha-lipoic acid |
| Q27008236 | Advances in the genomics of common eye diseases |
| Q39423391 | Aerobic Glycolysis Hypothesis Through WNT/Beta-Catenin Pathway in Exudative Age-Related Macular Degeneration |
| Q26771522 | Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration |
| Q35629702 | Age-related macular degeneration and mortality in older women: the study of osteoporotic fractures |
| Q34389315 | Age-related macular degeneration and risk of stroke |
| Q39786855 | Age-related macular degeneration in patients with uveitis |
| Q33263472 | Age-related macular degeneration--emerging pathogenetic and therapeutic concepts |
| Q37068063 | Age-related macular degeneration-clinical review and genetics update |
| Q34407622 | Age-related macular degeneration: genetic and environmental factors of disease |
| Q35084192 | Allosteric regulation of pathologic angiogenesis: potential application for angiogenesis-related blindness |
| Q64458843 | Almost total protection from age-related macular degeneration by haplotypes of the Regulators of Complement Activation |
| Q27311630 | Alternative complement pathway deficiency ameliorates chronic smoke-induced functional and morphological ocular injury |
| Q36056865 | An association between environmental factors and the IVS4+44C>A polymorphism of the DMT1 gene in age-related macular degeneration |
| Q35730294 | An association between polymorphism of the heme oxygenase-1 and -2 genes and age-related macular degeneration. |
| Q33903086 | Analysis of single nucleotide polymorphisms in the NOS2A gene and interaction with smoking in age-related macular degeneration |
| Q35071068 | Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degene |
| Q34251889 | Angiotensin II-related hypertension and eye diseases |
| Q34295974 | Antiangiogenic therapy for ischemic retinopathies |
| Q24201127 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q24242944 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q37612368 | Aspirin and age related macular degeneration; the possible relationship |
| Q34630065 | Aspirin use and risk of age-related macular degeneration: a meta-analysis |
| Q36763639 | Associated depression in pseudophakic patients with intraocular lens with and without chromophore |
| Q37725392 | Association between macular degeneration and mild to moderate chronic kidney disease: A nationwide population-based study |
| Q38967702 | Association between open-angle glaucoma and neovascular age-related macular degeneration: a case-control study. |
| Q38890900 | Association between visual acuity and medical and non-medical costs in patients with wet age-related macular degeneration in France, Germany and Italy |
| Q92524759 | Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39 |
| Q64111269 | Association of HTRA1 and ARMS2 gene polymorphisms with response to intravitreal ranibizumab among neovascular age-related macular degenerative subjects |
| Q36093266 | Association of macular pigment optical density with risk factors for wet age-related macular degeneration in the Indian population |
| Q57141419 | Association of obesity and age-related macular degeneration in Indian population |
| Q57539245 | Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population |
| Q35221016 | Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration |
| Q35596135 | Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration |
| Q64277869 | Big DNA as a tool to dissect an age-related macular degeneration-associated haplotype |
| Q48308521 | Blue light-filtering intraocular lenses and post-operative mood: a pilot clinical study |
| Q37220550 | Body mass index and binocular vision skills |
| Q37477257 | CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans |
| Q35140894 | CFH, VEGF, and PEDF genotypes and the response to intravitreous injection of bevacizumab for the treatment of age-related macular degeneration |
| Q33616519 | Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study |
| Q36516001 | Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study |
| Q58384520 | Cardiovascular risk factors associated with age-related macular degeneration: the Tromsø Study |
| Q49222689 | Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. |
| Q33434526 | Changes in retinal pigment epithelium related to cigarette smoke: possible relevance to smoking as a risk factor for age-related macular degeneration |
| Q33366509 | Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice |
| Q36058709 | Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration |
| Q34086893 | Cigarette smoke-related hydroquinone induces filamentous actin reorganization and heat shock protein 27 phosphorylation through p38 and extracellular signal-regulated kinase 1/2 in retinal pigment epithelium: implications for age-related macular deg |
| Q37585692 | Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and Age-related Macular Degeneration |
| Q89509850 | Circadian Rhythms in Exudative Age-Related Macular Degeneration: The Key Role of the Canonical WNT/β-Catenin Pathway |
| Q40526474 | Clinical features and long-term progression of reticular pseudodrusen in age-related macular degeneration: findings from a multicenter cohort |
| Q64117976 | Cohort profile: design and methods in the eye and vision consortium of UK Biobank |
| Q37321510 | Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort |
| Q54392848 | Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration. |
| Q24635874 | Complement in age-related macular degeneration: a focus on function |
| Q35974464 | Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells |
| Q43237426 | Corneal thickness in patients with age-related macular degeneration |
| Q35919480 | Correlation between the interactions of ABCA4 polymorphisms and smoking with the susceptibility to age-related macular degeneration |
| Q26998728 | Critical review: vegetables and fruit in the prevention of chronic diseases |
| Q33346235 | Density of common complex ocular traits in the aging eye: analysis of secondary traits in genome-wide association studies |
| Q33676775 | Development of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial |
| Q91586806 | Dietary Spirulina Supplementation Protects Visual Function From Photostress by Suppressing Retinal Neurodegeneration in Mice |
| Q37733102 | Dietary hyperglycemia, glycemic index and metabolic retinal diseases |
| Q38874774 | Differential effects of bevacizumab, ranibizumab and aflibercept on cell viability, phagocytosis and mitochondrial bioenergetics of retinal pigment epithelial cell |
| Q33747656 | Distinct signature of altered homeostasis in aging rod photoreceptors: implications for retinal diseases |
| Q37670089 | Does matrix metalloproteinase-3 polymorphism play a role in age-related macular degeneration in patients with myocardial infarction? |
| Q37314844 | Durable recovery of the macular architecture and functionality of a diagnosed age-related macular degeneration 1 year after a single intravitreal injection of dobesilate |
| Q33358167 | Dynamic indocyanine green angiography-guided focal thermal laser treatment of fibrotic choroidal neovascularization |
| Q92482674 | Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy |
| Q59810377 | Effects of Smoking on Outcomes of Antivascular Endothelial Growth Factor Therapy in Patients with Neovascular Age-Related Macular Degeneration Smoking and Anti-VEGF Therapy in nAMD |
| Q41619904 | Effects of body mass index on intraocular pressure and ocular pulse amplitude |
| Q42511711 | Effects of white light-emitting diode (LED) exposure on retinal pigment epithelium in vivo. |
| Q64053390 | Environmental stress impairs photoreceptor outer segment (POS) phagocytosis and degradation and induces autofluorescent material accumulation in hiPSC-RPE cells |
| Q37065197 | Estimated prevalence and risk factor for age-related maculopathy |
| Q36099741 | Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice |
| Q42080972 | Evaluation of ultraviolet light toxicity on cultured retinal pigment epithelial and retinal ganglion cells |
| Q55190215 | Evidence for an Association between Macular Degeneration and Thyroid Cancer in the Aged Population. |
| Q35552553 | Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies |
| Q34090408 | Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study |
| Q41836850 | Foveal slope measurements in subjects with high-risk of age-related macular degeneration |
| Q55172029 | Frequency of Cataract in Iran: A Meta-Analysis and Systematic Review. |
| Q93647591 | From the Library |
| Q36467703 | Functional single nucleotide polymorphism in IL-17A 3' untranslated region is targeted by miR-4480 in vitro and may be associated with age-related macular degeneration |
| Q99731189 | Gene networks determine predisposition to AMD |
| Q36849277 | Genetic Association Analysis of Drusen Progression |
| Q89700439 | Genetic and environmental factors strongly influence risk, severity and progression of age-related macular degeneration |
| Q37471769 | Genetic control of the alternative pathway of complement in humans and age-related macular degeneration |
| Q37901276 | Genetic factors associated with age-related macular degeneration |
| Q35907351 | Genetic polymorphism of the iron-regulatory protein-1 and -2 genes in age-related macular degeneration. |
| Q26738526 | Genetics and age-related macular degeneration: a practical review for the clinician |
| Q34691651 | Genetics and molecular pathology of Stargardt-like macular degeneration |
| Q34930448 | Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration |
| Q28074640 | Geographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review |
| Q36083959 | How does the macula protect itself from oxidative stress? |
| Q47263577 | HtrA1 Mediated Intracellular Effects on Tubulin Using a Polarized RPE Disease Model |
| Q47957566 | Identification of anti-retinal antibodies in patients with age-related macular degeneration. |
| Q64110252 | Imaging, Genetic, and Demographic Factors Associated With Conversion to Neovascular Age-Related Macular Degeneration: Secondary Analysis of a Randomized Clinical Trial |
| Q36739706 | Immunopathological aspects of age-related macular degeneration |
| Q33848714 | In-depth analyses unveil the association and possible functional involvement of novel RAD51B polymorphisms in age-related macular degeneration |
| Q34114772 | Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis |
| Q37186026 | Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration |
| Q35998709 | Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo |
| Q92624806 | Interaction between postmenopausal hormone therapy and diabetes on cataract |
| Q88985491 | Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes |
| Q36925652 | Intravitreal ranibizumab and bevacizumab: a review of risk |
| Q33844950 | Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms |
| Q55331943 | Is There a Relationship Between Use of Anti-Vascular Endothelial Growth Factor Agents and Atrophic Changes in Age-Related Macular Degeneration Patients? |
| Q38192127 | Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment |
| Q35491511 | Is aspirin use associated with age-related macular degeneration? A meta-analysis. |
| Q38171217 | Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. |
| Q32125469 | LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis |
| Q36516740 | Lack of association between the c.544G>A polymorphism of the heme oxygenase-2 gene and age-related macular degeneration |
| Q41398211 | Lack of association of CFD polymorphisms with advanced age-related macular degeneration. |
| Q40703905 | Light, lipids and photoreceptor survival: live or let die? |
| Q35138088 | Lipids, lipoproteins, and age-related macular degeneration |
| Q38915148 | Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related Macular Degeneration |
| Q37456134 | Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women |
| Q37117609 | Lutein acts via multiple antioxidant pathways in the photo-stressed retina |
| Q41111119 | Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model. |
| Q90158288 | Macula Ganglion Cell Thickness Changes Display Location-Specific Variation Patterns in Intermediate Age-Related Macular Degeneration |
| Q36517825 | Macular pigment optical density in the elderly: findings in a large biracial Midsouth population sample |
| Q34473284 | Metabolic syndrome triggered by high-fructose diet favors choroidal neovascularization and impairs retinal light sensitivity in the rat |
| Q35119852 | Mycoplasma pneumoniae and Chlamydia pneumoniae seropositivity in patients with age-related macular degeneration |
| Q89115884 | NAD+ and sirtuins in retinal degenerative diseases: A look at future therapies |
| Q26799766 | NLRP3 Inflammasome and Pathobiology in AMD |
| Q39471668 | Neovascular age-related macular degeneration is not associated with coronary heart disease in a Chinese Population: a population-based study |
| Q43071507 | Nicotine alters morphology and function of retinal pigment epithelial cells in mice |
| Q34620551 | No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 |
| Q42426609 | Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment |
| Q26821899 | Nutrient Supplementation for Age-related Macular Degeneration, Cataract, and Dry Eye |
| Q36758799 | Obesity and eye diseases |
| Q54650430 | Obesity-induced metabolic disturbance drives oxidative stress and complement activation in the retinal environment. |
| Q37543563 | Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System. |
| Q53075017 | Optic Nerve Parameters in Obese Children as Measured by Spectral Domain Optical Coherence Tomography. |
| Q38792215 | Optical Coherence Tomography Angiography of Dry Age-Related Macular Degeneration |
| Q35820353 | Optical coherence tomography changes before the development of choroidal neovascularization in second eyes of patients with bilateral wet macular degeneration |
| Q28741873 | Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components |
| Q33837372 | Patients' knowledge and perspectives on wet age-related macular degeneration and its treatment |
| Q48507644 | Photosensitization of A2E triggers telomere dysfunction and accelerates retinal pigment epithelium senescence. |
| Q34396842 | Plasma oxidized LDL and thiol-containing molecules in patients with exudative age-related macular degeneration |
| Q54212091 | Polymorphism of GST and FTO Genes in Risk Prediction of Cataract among a North Indian Population. |
| Q33396798 | Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables |
| Q37595089 | Predictors for the progression of geographic atrophy in patients with age-related macular degeneration: fundus autofluorescence study with modified fundus camera |
| Q51822278 | Predictors of psychological distress in caregivers of older persons with wet age-related macular degeneration. |
| Q37166529 | Predictors of visual response to intravitreal bevacizumab for treatment of neovascular age-related macular degeneration |
| Q38775043 | Prevalence of Age-Related Macular Degeneration in Slovakia and Associated Risk Factors: A Mobile Clinic-Based Cross-Sectional Epidemiological Survey |
| Q33739809 | Prevalence of and risk factors for age-related macular degeneration in Nepal: the Bhaktapur Retina Study |
| Q34491498 | Prevention of age-related macular degeneration |
| Q41995683 | Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration |
| Q36108106 | Prospectives for gene therapy of retinal degenerations |
| Q37379603 | Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells |
| Q35928791 | Pseudodrusen in the Fellow Eye of Patients with Unilateral Neovascular Age-Related Macular Degeneration: A Meta-Analysis |
| Q34646882 | Race- and sex-related differences in retinal thickness and foveal pit morphology. |
| Q33831237 | Ranibizumab for the treatment of degenerative ocular conditions |
| Q37211244 | Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study |
| Q36377333 | Recent advances in the management of dry age-related macular degeneration: A review |
| Q28088816 | Recent developments in the management of dry age-related macular degeneration |
| Q35503964 | Retina and omega-3. |
| Q37039797 | Review of genetics in age related macular degeneration. |
| Q38174238 | Review of the role of refined dietary sugars (fructose and glucose) in the genesis of retinal disease |
| Q57338306 | Rheopherese® bei altersbedingter Makuladegeneration |
| Q39942533 | Risk Factors for Progression of Early Age-Related Macular Degeneration in Koreans |
| Q34518363 | Risk characteristics of the combined geographic atrophy and choroidal neovascularisation phenotype in age-related macular degeneration. |
| Q38828895 | Risk factors and biomarkers of age-related macular degeneration |
| Q33720834 | Risk factors for age-related maculopathy |
| Q89888023 | Risk factors for progression of age-related macular degeneration |
| Q37612307 | Role of statins in the development and progression of age-related macular degeneration. |
| Q37715801 | Role of unfolded protein response dysregulation in oxidative injury of retinal pigment epithelial cells. |
| Q49373237 | SYSTEMIC BETA-BLOCKERS AND RISK OF PROGRESSION TO NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. |
| Q41788726 | Semenogelins in the human retina: Differences in distribution and content between AMD and normal donor tissues |
| Q82038879 | Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization |
| Q46887112 | Smokers' veins: a useful clinical sign--comment |
| Q34394380 | Smoking and age-related macular degeneration: review and update |
| Q84573245 | Smoking mice: a potential model for studying accumulation of drusen-like material on Bruch's membrane |
| Q35230959 | Smoking, antioxidant supplementation and dietary intakes among older adults with age-related macular degeneration over 10 years |
| Q40733341 | Socio-demographic characteristics, lifestyle factors and burden of morbidity associated with self-reported hearing and vision impairments in older British community-dwelling men: a cross-sectional study. |
| Q58708834 | Solar Radiation Exposure and Outdoor Work: An Underestimated Occupational Risk |
| Q44158875 | Statin use and the risk of age related macular degeneration in a large health organization in Israel |
| Q36350410 | Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration. |
| Q36350405 | Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population. |
| Q34657946 | Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition |
| Q89454097 | Systemic Disease and Long-term Intraocular Pressure Mean, Peak, and Variability in Nonglaucomatous Eyes |
| Q36791356 | Ten-year incidence of age-related macular degeneration according to diabetic retinopathy classification among medicare beneficiaries |
| Q39092535 | The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration |
| Q64905140 | The Challenges and Promise of Complement Therapeutics for Ocular Diseases. |
| Q24678569 | The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples |
| Q40957107 | The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement |
| Q34747861 | The association of smoking and alcohol use with age-related macular degeneration in the oldest old: the Study of Osteoporotic Fractures |
| Q35194580 | The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy |
| Q57186574 | The impact of lipids, lipid oxidation, and inflammation on AMD, and the potential role of miRNAs on lipid metabolism in the RPE |
| Q35676416 | The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis). |
| Q33828306 | The inhibition of NOTCH2 reduces UVB-induced damage in retinal pigment epithelium cells |
| Q37678798 | The molecular genetic basis of age-related macular degeneration: an overview |
| Q39024579 | The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target |
| Q33613367 | The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23 |
| Q36405906 | The role of inflammation in the pathogenesis of age-related macular degeneration |
| Q35624040 | The susceptibility of the retina to photochemical damage from visible light |
| Q39279676 | The use of heterochromatic flicker photometry to determine macular pigment optical density in a healthy Australian population. |
| Q42132169 | The vitreomacular interface in different types of age-related macular degeneration. |
| Q35530507 | Thyroid function: a new road to understanding age-related macular degeneration? |
| Q33950814 | Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples |
| Q37114046 | Toxicology of the retina: advances in understanding the defence mechanisms and pathogenesis of drug- and light-induced retinopathy |
| Q37223032 | Transcutaneous electrical retinal stimulation therapy for age-related macular degeneration |
| Q33226171 | Treatment of age-related macular degeneration. |
| Q36311846 | Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration |
| Q35182559 | Update on the role of genetics in the onset of age-related macular degeneration |
| Q37964705 | Use of herbal medicines and nutritional supplements in ocular disorders: an evidence-based review |
| Q36528747 | Verteporfin: a review of its use in the management of subfoveal choroidal neovascularisation |
| Q24676430 | Violet and blue light blocking intraocular lenses: photoprotection versus photoreception |
| Q35761985 | Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non-tinted intraocular lenses |
| Q34468393 | Visual prosthetic device for bilateral end-stage macular degeneration |
| Q36843128 | Vitamins for age-related macular degeneration demonstrate minimal differences |
| Q36171917 | Wnt signaling in age-related macular degeneration: human macular tissue and mouse model |
| Q39538297 | ZIP2 and ZIP4 mediate age-related zinc fluxes across the retinal pigment epithelium |
| Q46718576 | Zeaxanthin is bioavailable from genetically modified zeaxanthin-rich potatoes |
| Q48214364 | Zinc Protects Oxidative Stress-Induced RPE Death by Reducing Mitochondrial Damage and Preventing Lysosome Rupture |
| Q34500204 | Zinc transporter 8 (ZnT8) expression is reduced by ischemic insults: a potential therapeutic target to prevent ischemic retinopathy |
| Q80476063 | [Toward prevention of age-related macular degeneration] |
| Q52916673 | [Vitamins for the eyes? Risks and opportunities for physician and patient]. |
Search more.